{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:03:47Z","timestamp":1790964227299,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019034","name":"Hubei Provincial Central Guidance Local Science and Technology Development Project","doi-asserted-by":"publisher","award":["YDZJSX20231A059"],"award-info":[{"award-number":["YDZJSX20231A059"]}],"id":[{"id":"10.13039\/501100019034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019034","name":"Hubei Provincial Central Guidance Local Science and Technology Development Project","doi-asserted-by":"publisher","award":["YDZJSX2022A059"],"award-info":[{"award-number":["YDZJSX2022A059"]}],"id":[{"id":"10.13039\/501100019034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404445"],"award-info":[{"award-number":["82404445"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117305","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:49:18Z","timestamp":1757000958000},"page":"117305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["Sappanone A, a potential natural inhibitor of PI3K, alleviates metabolic dysfunction-associated steatohepatitis in experimental models"],"prefix":"10.1016","volume":"242","author":[{"given":"Xi","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-3127","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2025.117305_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.bcp.2025.117305_b0010","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2025.117305_b0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2025.117305_b0020","article-title":"First US drug approved for a liver disease surging around the world","author":"Ledford","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2025.117305_b0025","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1021\/jm4019299","volume":"57","author":"Kelly","year":"2014","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.117305_b0030","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/acs.jmedchem.2c01669","article-title":"Discovery of highly potent and selective thyroid hormone receptor \u03b2 agonists for the treatment of nonalcoholic steatohepatitis","volume":"66","author":"Hu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117305_b0035","article-title":"Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2025.117305_b0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2147\/DDDT.S404055","article-title":"Cinchonine, a potential oral small-molecule glucagon-like peptide-1 receptor agonist lowers blood glucose and ameliorates non-alcoholic steatohepatitis","volume":"17","author":"Xue","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2025.117305_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the first 1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2025.117305_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad142","article-title":"Decoding Connectivity Map-based drug repurposing for oncotherapy","volume":"24","author":"Zhao","year":"2023","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bcp.2025.117305_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117202","article-title":"GLP-1R mediates idebenone-reduced blood glucose in mice","volume":"178","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2025.117305_b0060","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.4145","article-title":"Withaferin a is a leptin sensitizer with strong antidiabetic properties in mice","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2025.117305_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117305_b0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.phrs.2019.04.016","article-title":"Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH","volume":"144","author":"Boeckmans","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117305_b0075","article-title":"A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.117305_b0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chroma.2005.04.050","article-title":"Development and optimization of a method for the analysis of Brazilein by HPLC with electrochemical detection","volume":"1077","author":"Yan","year":"2005","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.bcp.2025.117305_b0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jep.2013.03.050","article-title":"Identification of active compounds from Caesalpinia sappan L. extracts suppressing IL-6 production in RAW 264.7 cells by PLS","volume":"148","author":"Chu","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2025.117305_b0090","doi-asserted-by":"crossref","unstructured":"I. Noortje, J. Aafke W F, M. Alexandra, R.P. Jos\u00e9 M, H. Danielle A A, M. Michal, B. Bark, B. Frits J, J. Ignace M, v.M. Saskia W C, K.J.J.H. Sander, Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid, 64(5) (2016).","DOI":"10.1016\/j.jhep.2016.01.016"},{"issue":"5","key":"10.1016\/j.bcp.2025.117305_b0095","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.29607","article-title":"Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science","volume":"67","author":"Siddiqui","year":"2018","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.bcp.2025.117305_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113141","article-title":"A Gedunin-Type Limonoid, 7-Deacetoxy-7-Oxogedunin, from Andiroba (Carapa guianensis Aublet) Reduced Intracellular Triglyceride Content and Enhanced Autophagy in HepG2 Cells","volume":"23","author":"Nagatomo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117305_b0105","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ptr.7334","article-title":"Activation of PGC-1\u03b1 via isoliquiritigenin-induced downregulation of miR-138-5p alleviates nonalcoholic fatty liver disease","volume":"36","author":"Wang","year":"2022","journal-title":"Phytother. Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117305_b0110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12894","article-title":"Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.bcp.2025.117305_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.bcp.2025.117305_b0120","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"10","key":"10.1016\/j.bcp.2025.117305_b0125","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117305_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111572","article-title":"Hepatic stellate cell senescence in liver fibrosis: characteristics, mechanisms and perspectives","volume":"199","author":"Zhang","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2025.117305_b0135","doi-asserted-by":"crossref","DOI":"10.4093\/dmj.2024.0532","article-title":"Interleukin 33 promotes liver sinusoidal endothelial cell dysfunction and hepatic fibrosis in diabetic mice","author":"Chen","year":"2025","journal-title":"Diabetes Metab. J."},{"issue":"11","key":"10.1016\/j.bcp.2025.117305_b0140","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.7150\/ijbs.26086","article-title":"Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice","volume":"14","author":"Li","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117305_b0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.bcp.2025.117305_b0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep4.1298","article-title":"An inhibitor of arginine-glycine-aspartate-binding integrins reverses fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"3","author":"Ulmasov","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2025.117305_b0155","article-title":"Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)","volume":"245","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117305_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154148","article-title":"Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy","volume":"102","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.bcp.2025.117305_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115851","article-title":"One week of CDAHFD induces steatohepatitis and mitochondrial dysfunction with oxidative stress in liver","volume":"22","author":"Sugasawa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117305_b0170","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117305_b0175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.30213","article-title":"Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood","volume":"69","author":"Ghallab","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2025.117305_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115279","article-title":"Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade","volume":"165","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117305_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155073","article-title":"Network pharmacology analysis and animal experiment validation of neuroinflammation inhibition by total ginsenoside in treating CSM","volume":"126","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2025.117305_b0190","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2021-0067","article-title":"MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K\/AKT signaling pathway","volume":"45","author":"Xu","year":"2022","journal-title":"Genet. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117305_b0195","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gutjnl-2023-330826","article-title":"High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT","volume":"73","author":"Bu","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2025.117305_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109808","article-title":"Natural molecule isoliquiritigenin mitigates MASH and liver fibrosis in mice by promoting autophagy through the PI3K\/Akt signaling pathway","volume":"136","author":"Liu","year":"2025","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117305_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","article-title":"Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism","volume":"21","author":"Zhang","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.bcp.2025.117305_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154684","article-title":"Hydroxysafflor yellow a regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT\/mTOR and NF-\u03baB pathway in macrophages to reduce atherosclerosis in ApoE-\/- mice","volume":"112","author":"Feng","year":"2023","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.bcp.2025.117305_b0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpha.2023.03.006","article-title":"Ginsenoside Rk3 is a novel PI3K\/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma","volume":"13","author":"Qu","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bcp.2025.117305_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108593","article-title":"Berberine prevents NAFLD and HCC by modulating metabolic disorders","volume":"254","author":"Lin","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"35","key":"10.1016\/j.bcp.2025.117305_b0225","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.3748\/wjg.v30.i35.3965","article-title":"Peroxisome proliferator-activated receptor agonists: a new hope towards the management of alcoholic liver disease","volume":"30","author":"Durairajan","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2025.117305_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1549277","article-title":"PI3K\/Akt in IPF: untangling fibrosis and charting therapies","volume":"16","author":"Bhatt","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117305_b0235","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s43018-021-00218-4","article-title":"The present and future of PI3K inhibitors for cancer therapy","volume":"2","author":"Castel","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.bcp.2025.117305_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113633","article-title":"PI3K inhibition reduces murine and human liver fibrogenesis in precision-cut liver slices","volume":"169","author":"Gore","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117305_b0245","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13287-022-02832-0","article-title":"Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K\/AKT signaling pathway","volume":"13","author":"Aierken","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117305_b0250","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1142\/S0192415X16500415","article-title":"Timosaponin B-II Ameliorates Palmitate-Induced Insulin Resistance and Inflammation via IRS-1\/PI3K\/Akt and IKK\/NF-[Formula: see text]B Pathways","volume":"44","author":"Yuan","year":"2016","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.bcp.2025.117305_b0255","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","article-title":"Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3K\/pAkt\/NF\u03baB signaling","volume":"55","author":"Urtasun","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2025.117305_b0260","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117305_b0265","doi-asserted-by":"crossref","unstructured":"X. Xiaohan, P. Kyle L, W. Lijuan, L. Shan, M. Tatsunori, S. Qiaoling, W. Qingda, Z. Chenyang, L. Chunhua, Y.J.S.T.T.T. Jinbo, Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH), 7(1) (2022).","DOI":"10.1038\/s41392-022-01119-3"},{"issue":"10","key":"10.1016\/j.bcp.2025.117305_b0270","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41573-021-00209-1","article-title":"PI3K inhibitors are finally coming of age","volume":"20","author":"Vanhaesebroeck","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:26:54Z","timestamp":1762097214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0006295225005702"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117305","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sappanone A, a potential natural inhibitor of PI3K, alleviates metabolic dysfunction-associated steatohepatitis in experimental models","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117305"}}